Affiliation:
1. Sunnybrook Research Institute, University of Toronto, Toronto, Ontario M4N 3M5, Canada and Technion – Israel Institute of Technology, Haifa 3200003, Israel
Abstract
In this issue of JEM, Chan et al. describe a novel way by which an investigational form of chemotherapy known as low-dose metronomic chemotherapy can inhibit tumor growth, which also has therapeutic implications for targeting tumor-initiating cells (TICs), the tumor stroma, and chemokine receptors, as well as invasion and metastasis.
Publisher
Rockefeller University Press
Subject
Immunology,Immunology and Allergy
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献